← Back to headlines
TD Cowen Raises Price Target on Roivant Sciences
TD Cowen, a financial services firm, has increased its price target for Roivant Sciences (ROIV) stock, indicating a positive outlook on the pharmaceutical company's future performance.
Sources
Showing 0 of 1 sources
No articles available in your preferred languages.
1 article available in other languages below.
Related Stories
Brookfield Structures $1.8 Billion Bond Deal to Fund $600 Million Dividend
45m ago
Nigeria Reports 4.43 Percent Economic Growth in Second Quarter
50m ago
Prediction Platform Kalshi Permanently Bans George Santos Over Insider Trading
52m ago
Pabst Brewing Offers 'No Questions Asked' Reward for Stolen Beer
1h ago